Akebia Therapeutics, Inc. (AKBA)
0.9001
-0.01
(-0.72%)
USD |
NASDAQ |
Aug 24, 16:00
0.9001
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Shareholders Equity (Quarterly) : 25.02M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.02M |
| March 31, 2026 | 27.38M |
| December 31, 2025 | 32.61M |
| September 30, 2025 | 41.59M |
| June 30, 2025 | 29.22M |
| March 31, 2025 | 24.58M |
| December 31, 2024 | -49.18M |
| September 30, 2024 | -50.40M |
| June 30, 2024 | -33.75M |
| March 31, 2024 | -27.26M |
| December 31, 2023 | -30.58M |
| September 30, 2023 | -39.42M |
| June 30, 2023 | -26.81M |
| March 31, 2023 | -14.35M |
| December 31, 2022 | 5.23M |
| September 30, 2022 | 13.85M |
| June 30, 2022 | 62.30M |
| March 31, 2022 | 26.12M |
| December 31, 2021 | 74.01M |
| September 30, 2021 | 137.15M |
| June 30, 2021 | 174.63M |
| March 31, 2021 | 213.89M |
| December 31, 2020 | 247.62M |
| September 30, 2020 | 317.96M |
| June 30, 2020 | 370.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 396.36M |
| December 31, 2019 | 394.76M |
| September 30, 2019 | 467.56M |
| June 30, 2019 | 519.36M |
| March 31, 2019 | 566.38M |
| December 31, 2018 | 635.93M |
| September 30, 2018 | 142.54M |
| June 30, 2018 | 165.92M |
| March 31, 2018 | 197.10M |
| December 31, 2017 | 122.57M |
| September 30, 2017 | 99.88M |
| June 30, 2017 | 57.00M |
| March 31, 2017 | 30.62M |
| December 31, 2016 | 68.12M |
| September 30, 2016 | 100.71M |
| June 30, 2016 | 133.29M |
| March 31, 2016 | 167.76M |
| December 31, 2015 | 131.00M |
| September 30, 2015 | 145.41M |
| June 30, 2015 | 149.75M |
| March 31, 2015 | 94.61M |
| December 31, 2014 | 104.08M |
| September 30, 2014 | 113.61M |
| June 30, 2014 | 121.55M |
| March 31, 2014 | 127.87M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Emergent BioSolutions, Inc. | 341.40M |
| Exelixis, Inc. | 1.844B |
| ADMA Biologics, Inc. | 408.21M |
| Arcutis Biotherapeutics, Inc. | 220.58M |
| Relay Therapeutics, Inc. | 890.01M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 349.66M |
| Total Liabilities (Quarterly) | 324.64M |
| Debt to Equity Ratio | 8.426 |
| Current Ratio | 1.427 |
| Net Debt Paydown Yield | -0.30% |